Validation of the grown-ups with congenital heart disease score

Jürgen Hörer1, Régine Roussin1, Emanuel LeBret1

  • 1Department of Pediatric Cardiology and Congenital Heart Disease, Hopital Marie Lannelongue, Université Paris-Sud, Le Plessis Robinson, France.

Insights

The GUCH mortality score accurately predicts postoperative mortality in adults undergoing congenital heart disease surgery. This validation confirms its utility for risk assessment in this complex patient group.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Health Outcomes Research

Background:

  • Adults with congenital heart disease (ACHD) often have comorbidities and require complex cardiac surgery.
  • Redo operations in ACHD patients increase risks of mortality and morbidity.
  • Existing risk scores may not fully capture the complexities of ACHD surgery.

Purpose of the Study:

  • To validate the predictive accuracy of the recently proposed Grown-ups with Congenital Heart Disease (GUCH) mortality and morbidity scores.
  • To assess the performance of GUCH scores in a large, single-center cohort of adult patients undergoing congenital heart surgery.

Main Methods:

  • Retrospective analysis of 824 consecutive adult congenital heart disease surgeries performed between 2005 and 2016.
  • Definition of mortality (hospital or 30-day) and morbidity (specific complications including renal failure, neurologic deficit, AV block, circulatory support, phrenic nerve injury, reoperation).
  • Assessment of GUCH score discriminatory power using the area under the receiver operating characteristics curve (c-index).

Main Results:

  • The study evaluated 824 operations in adults with congenital heart disease.
  • Hospital mortality was 3.4% and morbidity was 10.0%.
  • The GUCH mortality score demonstrated strong predictive power (c-index = 0.809), while the GUCH morbidity score showed moderate predictive power (c-index = 0.676).

Conclusions:

  • The GUCH mortality score is a reliable tool for predicting postoperative mortality in adults with congenital heart disease.
  • Validation in a large cohort supports the use of GUCH scores for risk stratification in this population.
  • Further evaluation of the GUCH morbidity score may be warranted.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
791
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
441
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
539
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
299
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
300
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
800